Incremental utility of circulating biomarkers for cardiovascular risk prediction beyond the updated SCORE2 model
Jonas Lehmacher(Universität Hamburg), Raphael Twerenbold(German Centre for Cardiovascular Research), Barbara Thorand(Helmholtz Zentrum München), Wolfgang Köenig(German Centre for Cardiovascular Research), Stefan Blankenberg(Universität Hamburg), Licia Iacoviello(Istituto Neurologico Mediterraneo), Kari Kuulasmaa(Finnish Institute for Health and Welfare), Alina Goßling, Hugh Tunstall‐Pedoe(University of Dundee), Allan Linneberg(Frederiksberg Hospital), S Soederberg(Umeå University), Maurizio Ferrario(University of Insubria), Betül Toprak(Universität Hamburg), Luigi Palmieri(Istituto Superiore di Sanità), T Zeller(Universität Hamburg)
Cited by 1
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.7k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.3k
SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe
|European Heart Journal|2021|1.7k